ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Posaconazol Devatis 40mg/ml, Suspension zum Einnehmen - 105 ml
67594001 Devatis AG
Posaconazol Devatis 40mg/ml, Suspension zum Einnehmen06.08.2020
Generic06.08.2020
Posaconazole (J02AC04) 
WHO-DDD05.08.2025
08.06.105 ml
08.06. 
B  
Yes 
IPCI
513.14Yes
    
10 %606.10
7680675940011Synthetika
  
Composition
posaconazolum 200 mg, polysorbatum 80, xanthani gummi, natrii benzoas 10 mg, acidum citricum monohydricum, natrii citras dihydricus, glycerolum, glucosum liquidum 1750 mg, E 171, simeticonum, polysorbatum 65, methylcellulosum, macrogoli stearas, mono/diglycerida, E 200, E 210 0.045 mg, acidum sulfuricum, aromatica (Kirschen) cum propylenglycolum 14.35 mg, aqua purificata ad suspensionem pro 5 ml corresp. natrium 3.4 mg.
Packungsbestandteile
Suspension (oral) 
  
 
Active AgentDose
Posaconazole200mg / 5ml
BAG: Active AgentDose
Posaconazole200 mg
 
Inactive agentsDoseadditional_information
Citric Acid Monohydrate  
Sulfuric Acid  
Aromatica (Kirschen) cum Propylenglycolum14.35mg / 5ml 
E 171 color.
E 200 conserv.
E 2100.045mg / 5mlconserv.
Glucosum Liquidum1750mg / 5ml 
Glycerol  
Macrogoli Stearas  
Methylcellulosum  
Mono/diglycerida  
Sodium Benzoate10mg / 5ml 
Natrii Citras Dihydricus  
Polysorbatum 65  
Polysorbatum 80  
Simeticone  
Xanthani Gummi  
 
Source
Data was imported : 06.02.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home